Dermatology and Skin Diseases

Atopic dermatitis is a chronic inflammatory skin condition driven by a breakdown in the epithelial barrier, where mutations in the gene encoding filaggrin compromise the skin's ability to retain moisture and exclude irritants, triggering a cascade of immune dysregulation. The resulting inflammation draws in bacteria like Staphylococcus aureus and involves signaling molecules such as TSLP, which push the immune system toward the allergic responses responsible for the characteristic itch—pruritus—that severely affects patients' quality of life. Biologic therapies like dupilumab, which blocks key inflammatory pathways, have transformed treatment for moderate-to-severe cases, yet researchers are still working out why responses vary between patients and how the skin microbiome shapes both disease severity and treatment outcomes. Understanding the precise interplay between barrier genetics, microbial ecology, and immune signaling remains an active frontier with direct implications for preventing atopic dermatitis from progressing into asthma and other allergic conditions.

Works

99,951

Total citations

1,423,892

Keywords

FilaggrinSkin MicrobiomeTSLPEczemaImmune DysregulationPruritus